Sheng Chao Wang

Director/Board Member en YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. .

Fortuna: 44 485 $ al 31/03/2024

41 años

Health Technology

Consumer Services

Perfil

Sheng Chao Wang is currently a Member-Supervisory Board at YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
and HEC Pharm Co., Ltd.
He obtained his undergraduate degree from Shenyang Pharmaceutical University in 2008.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO. LTD. CLASS H 0.00%	30/06/2023	32 000 ( 0.00% )	44 485 $	31/03/2024

Cargos activos de Sheng Chao Wang

Empresas	Cargo	Inicio
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.	Director/Board Member	21/07/2017
HEC Pharm Co., Ltd. HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China.	Director/Board Member	-

Todos los cargos activos de Sheng Chao Wang

Formación de Sheng Chao Wang.

Shenyang Pharmaceutical University

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Sheng Chao Wang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.	Health Technology

Empresas privadas	1
HEC Pharm Co., Ltd. HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China.	Health Technology